Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Cash from Investing Activities (2022 - 2024)

Historic Cash from Investing Activities for Coya Therapeutics (COYA) over the last 3 years, with Q1 2024 value amounting to -$25000.0.

  • Coya Therapeutics' Cash from Investing Activities changed N/A to -$25000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was -$25000.0, marking a year-over-year change of. This contributed to the annual value of -$25000.0 for FY2024, which is 9539.75% up from last year.
  • According to the latest figures from Q1 2024, Coya Therapeutics' Cash from Investing Activities is -$25000.0.
  • In the past 5 years, Coya Therapeutics' Cash from Investing Activities ranged from a high of -$25000.0 in Q1 2024 and a low of -$390000.0 during Q4 2022
  • Moreover, its 3-year median value for Cash from Investing Activities was -$193186.0 (2023), whereas its average is -$202728.7.
  • Over the last 5 years, Coya Therapeutics' Cash from Investing Activities had its largest YoY gain of 5046.51% in 2023, and its largest YoY loss of 5046.51% in 2023.
  • Over the past 3 years, Coya Therapeutics' Cash from Investing Activities (Quarter) stood at -$390000.0 in 2022, then surged by 50.47% to -$193186.0 in 2023, then surged by 87.06% to -$25000.0 in 2024.
  • Its last three reported values are -$25000.0 in Q1 2024, -$193186.0 for Q4 2023, and -$390000.0 during Q4 2022.